#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Congenital growth hormone deficiency Bronchiectasis Urea cycle disorder Metastatic malignant melanoma Cerebral arteriovenous malformation haemorrhagic Extranodal marginal zone B-cell lymphoma (MALT type) Idiopathic pulmonary fibrosis Transferrin decreased Chronic lymphocytic leukaemia recurrent Hepatitis B Small cell lung cancer Infective uveitis Oesophageal atresia Ocular myasthenia Acute myeloid leukaemia refractory More trials…

    Learn about Rare Diseases

    Propionic acidaemia Antisynthetase syndrome – Basic Information Pleomorphic leiomyosarcoma – Basic Information Gaucher’s disease type I – Treatment Haemophilia A with anti factor VIII – Trials in Disease Sjogren’s syndrome – Life with Disease Rhabdomyosarcoma recurrent – Trials in Disease Lennox-Gastaut syndrome – Diagnostics Angiosarcoma non-metastatic – Life with Disease Nodal marginal zone B-cell lymphoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Guanfacine Barzolvolimab Avalglucosidase Alfa HYDROMORPHONE HYDROCHLORIDE Emedastine ABIRATERONE DECANOATE Nilotinib Abc-15A-116 Romosozumab Zilucoplan Sodium Progesterone Ph. Eur. Calcifediol Streptococcus Agalactiae Toldc Thiopental Sodium INF904 BW-20805 Bempedoic Acid Deutivacaftor Mometasone Furoate More therapies…

    Learn about Your Condition

    Hyperinsulinism Oxygen therapy Cataract Oesophageal cancer metastatic Dupuytren's contracture Pancreatic carcinoma Gender dysphoria Factor IX deficiency Erythema Pemphigoid Methylmalonic acidaemia Biotinidase deficiency Neurofibromatosis High-grade B-cell lymphoma Pseudomyxoma peritonei More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Lisaftoclax and Acalabrutinib for Patients with Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Lisaftoclax
    • Zanubrutinib
    • Acalabrutinib
    Belgium Bulgaria Czechia France Germany Hungary +5

  • Study on the Safety and Efficacy of a Hepatitis B Vaccine with Hepatitis B Surface Antigen (rDNA), MVA-HBVAC, and Mosaic HBcoreAg for Adults with Chronic Hepatitis B

    Recruiting

    1 1 1
    Investigated Drugs:
    • Mosaic Hbcoreag
    • Mva-Hbvac
    Germany Spain

  • Study on Reducing Antiplatelet Therapy in Patients with Acute Coronary Syndrome and High Bleeding Risk Using Prasugrel, Ticagrelor, or Clopidogrel

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute coronary syndrome
    Investigated Drugs:
    • Prasugrel
    • Clopidogrel
    • Ticagrelor
    Italy

  • Study on Reducing Cardiovascular Disease in Type 1 Diabetes Patients Using Finerenone and Semaglutide

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Type 1 diabetes mellitus
    Investigated Drugs:
    • Sotagliflozin
    • Finerenone
    • Semaglutide
    Denmark

  • Study on the Effectiveness and Safety of TPST-1120 and Drug Combination for Patients with Advanced Liver Cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Hepatocellular carcinoma
    Investigated Drugs:
    • 3-Fluoro-5-{[(2Ar,4S)-1,1,2,2,4-Pentafluoro-2A-Hydroxy-2,2A,3,4-Tetrahydro-1H-Cyclopenta[Cd]Inden-5-Yl]Oxy}Benzonitrile
    • Adg126
    • Human Igg4 Monoclonal Antibody Against Lilrb2
    France

  • Study of Inebilizumab for Children and Adolescents with Neuromyelitis Optica Spectrum Disorder

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neuromyelitis optica spectrum disorder
    Investigated Drugs:
    • Inebilizumab
    France The Netherlands Poland Spain Sweden
Previous Page
1 … 482 483 484 485 486 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!